Kiersten Stead Location
San Francisco, United States
Kiersten Stead Work
- 2024–nowBoard Member @ Nilo Therapeutics
- 2024–nowBoard Member @ Radionetics Oncology
- 2024–nowBoard Member @ Latus Bio
- 2024–nowBoard Member @ Totus Medicines
See more
- 2019–nowBoard Member @ Mycoworks
- 2018–nowManaging Partner @ DCVC Bio
- 2014–nowSAB @ Keystone Symposia on Molecular & Cellular Biology
- 2021–2024Board Member @ Stemson Therapeutics
- 2022–2024Board Member @ Elo Life Systems
- 2021–2024Board Member @ Creyon Bio
- 2018–2024Board Member @ Sabanto
- 2019–2022Board Member @ Verdant Robotics, Inc.
- 2018–2022Board Member @ Plexium
- 2018–2021Board Member @ GenEdit
- 2013–2020Core Evaluation Team, Genomic Applications Partnership Program @ Genome Canada
- 2017–2018Board Member and Co-Founder @ Pairwise Plants
- 2017–2018Board Member @ Combyne Ag
- 2016–2018Board Observer @ Understory, Inc.
- 2015–2018Board Member @ PlantResponse Biotech
- 2013–2018Investment Director @ Monsanto Growth Ventures
- 2015–2017Board Observer @ Blue River Technology
- 2015–2016Member Board Of Directors @ VitalFields
- 2011–2013Venture Capital @ Burrill & Company
- 2010–2011Business Development Associate @ TEC Edmonton
- 2009–2011Scholar @ AHFMR ForeFront MBA
- 2009–2010Research Associate @ University of Alberta
- 2007–2009Post-Doc @ University of Alberta
Kiersten Stead Investing
Managing Partner at DCVC Bio
- Stages
- Seed, Series A
- Sectors
- Health tech
- Cheque size
- €4.6M–€23M
- Freshness
- Verified 1mo ago
Kiersten Stead Summary
Kiersten Stead, based in San Francisco, United States, is a Managing Partner at DCVC Bio. Kiersten Stead invests in Health tech at Seed and Series A, writing €4.6M–€23M cheques. Kiersten Stead brings experience from Nilo Therapeutics, Radionetics Oncology, Latus Bio and Totus Medicines. Kiersten Stead's verified email and contact details are available on Mintround.
How to cold email Kiersten Stead
Kiersten Stead, DCVC Bio in San Francisco, United States, backs Health tech companies at Seed and Series A, writing €4.6M–€23M cheques. Here's how to get a reply when you cold email Kiersten:
- Subject line: name your company and one metric that matters to Health tech, not “quick chat”.
- First line: your strongest traction, the real numbers, not adjectives.
- One ask: a 20-minute call with a date range. Keep it under 150 words.
- Send it to Kiersten's verified address below. No warm intro required.
Every contact is a verified, deliverable email. How Mintround verifies contacts.
Are you Kiersten Stead? Request removal of this listing.